日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Venetoclax in Previously Treated Waldenström Macroglobulinemia

维奈托克用于既往接受过治疗的华氏巨球蛋白血症

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01194
Castillo, Jorge J; Allan, John N; Siddiqi, Tanya; Advani, Ranjana H; Meid, Kirsten; Leventoff, Carly; White, Timothy P; Flynn, Catherine A; Sarosiek, Shayna; Branagan, Andrew R; Demos, Maria G; Guerrera, Maria L; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nicholas; Xu, Lian; Yang, Guang; Patterson, Christopher J; Hunter, Zachary R; Davids, Matthew S; Furman, Richard R; Treon, Steven P
发表日期：2022
文献求助 收藏

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia

对初治华氏巨球蛋白血症患者进行伊布替尼单药治疗的长期随访

期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-021-01417-9
Castillo, Jorge J; Meid, Kirsten; Gustine, Joshua N; Leventoff, Carly; White, Timothy; Flynn, Catherine A; Sarosiek, Shayna; Demos, Maria G; Guerrera, Maria L; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nicholas; Xu, Lian; Yang, Guang; Branagan, Andrew R; O'Donnell, Elizabeth; Raje, Noopur; Yee, Andrew J; Patterson, Christopher J; Hunter, Zachary R; Treon, Steven P
发表日期：2022
文献求助 收藏

Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy

对伊布替尼单药治疗产生耐药性后，Waldenström巨球蛋白血症的自然病程

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2021.279112
Gustine, Joshua N; Sarosiek, Shayna; Flynn, Catherine A; Meid, Kirsten; Leventoff, Carly; White, Timothy; Guerrera, Maria Luisa; Xu, Lian; Kofides, Amanda; Tsakmaklis, Nicholas; Munshi, Manit; Demos, Maria; Patterson, Christopher J; Liu, Xia; Yang, Guang; Hunter, Zachary R; Branagan, Andrew R; Treon, Steven P; Castillo, Jorge J
发表日期：2022
文献求助 收藏

A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinib

一项关于达沙替尼治疗伊布替尼治疗后病情进展的华氏巨球蛋白血症患者的初步研究

期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.493
Castillo, Jorge J; Sarosiek, Shayna; Flynn, Catherine A; Leventoff, Carly; Little, Megan; White, Timothy; Meid, Kirsten; Treon, Steven P
发表日期：2022
文献求助 收藏

Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia

伊布替尼联合CXCR4拮抗剂ulocuplumab治疗CXCR4突变型华氏巨球蛋白血症的I期研究

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2021012953
Treon, Steven P; Meid, Kirsten; Hunter, Zachary R; Flynn, Catherine A; Sarosiek, Shayna R; Leventoff, Carly R; White, Timothy P; Cao, Yang; Roccaro, Aldo M; Sacco, Antonio; Demos, Maria G; Guerrera, Maria Luisa; Kofides, Amanda; Liu, Xia; Xu, Lian; Patterson, Christopher J; Munshi, Manit; Tsakmaklis, Nicholas; Yang, Guang; Ghobrial, Irene M; Branagan, Andrew R; Castillo, Jorge J
CXCR4
发表日期：2021
文献求助 收藏

Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88(L265P) in Waldenström Macroglobulinemia

诊断性二代测序经常无法检测到华氏巨球蛋白血症中的MYD88(L265P)突变

期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000624
Kofides, Amanda; Hunter, Zachary R; Xu, Lian; Tsakmaklis, Nicholas; Demos, Maria G; Munshi, Manit; Liu, Xia; Guerrera, Maria Luisa; Leventoff, Carly R; White, Timothy P; Flynn, Catherine A; Meid, Kirsten; Patterson, Christopher J; Yang, Guang; Branagan, Andrew R; Sarosiek, Shayna; Castillo, Jorge J; Treon, Steven P; Gustine, Joshua N
MYD88
发表日期：2021
文献求助 收藏

Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia

一项针对既往接受过治疗的华氏巨球蛋白血症患者的达雷妥尤单抗单药治疗的多中心 II 期研究

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2020003087
Castillo, Jorge J; Libby, Edward N; Ansell, Stephen M; Palomba, M Lia; Meid, Kirsten; Flynn, Catherine A; Leventoff, Carly; Hergott, Christopher B; Sewastianik, Tomasz; Morgan, Elizabeth A; Carrasco, Ruben; Fromm, Jonathan R; Yang, Guang; Hunter, Zachary; Treon, Steven P
发表日期：2020
文献求助 收藏